denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.Hematology Disease Topics & Pathways:
Research, Sickle Cell Disease, adult, Clinical Practice (Health Services and Quality), epidemiology, Workforce, Clinical Research, Diversity, Equity, and Inclusion (DEI) , Hemoglobinopathies, Diseases, pregnant, Study Population, Human, Maternal Health
Description:
Pregnancy in women with sickle cell disease (SCD) is a life-threatening condition. In a pooled analysis from recent obstetric and hematology studies conducted in low- and middle-income settings, maternal death in women with SCD is approximately 2,393 and 4,300 deaths per 100,000 live births with and without multidisciplinary care, respectively. In comparison, the USA and Northern Europe's general maternal mortality rate is approximately 23.8 and 8 deaths per 100,000 live births, respectively.
Dr. Eugenia Vicky Asare will highlight the added value of a combined obstetric and sickle cell disease outpatient and inpatient care program to integrate evidence based-management for SCD-related acute pain, acute chest syndrome, and pulmonary thromboembolism. Using the multidisciplinary SCD obstetrics care approach in Ghana, she will highlight best-integrated clinical practices to decrease SCD-related morbidity and mortality in pregnant women with SCD.
Dr. Bosede Afolabi will speak on the difficulties in diagnosing complications in pregnant women with SCD in LMICs, emphasizing Nigeria, the country with the most significant number of individuals living with SCD worldwide. She will discuss the evidence-based preventive and therapeutic options available to treat pregnant women with SCD and the innovations and adaptations used in LMICs to substitute for limited resources.
Dr. Eugene Oteng-Ntim will discuss the Evidence-Based Management of Pregnant Women with SCD in High-Income Countries.
Dr. Eugenia Vicky Asare will highlight the added value of a combined obstetric and sickle cell disease outpatient and inpatient care program to integrate evidence based-management for SCD-related acute pain, acute chest syndrome, and pulmonary thromboembolism. Using the multidisciplinary SCD obstetrics care approach in Ghana, she will highlight best-integrated clinical practices to decrease SCD-related morbidity and mortality in pregnant women with SCD.
Dr. Bosede Afolabi will speak on the difficulties in diagnosing complications in pregnant women with SCD in LMICs, emphasizing Nigeria, the country with the most significant number of individuals living with SCD worldwide. She will discuss the evidence-based preventive and therapeutic options available to treat pregnant women with SCD and the innovations and adaptations used in LMICs to substitute for limited resources.
Dr. Eugene Oteng-Ntim will discuss the Evidence-Based Management of Pregnant Women with SCD in High-Income Countries.